AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23153410
Drug: Post-prescription review
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-prescription review by the infectious disease physician (IDP)
Trial: 19048842
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with melatonin
Trial: 27974224
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (treatment and control)
Trial: 8498949
Drug: Levonorgestrel-containing pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonorgestrel-containing pill
Trial: 30843767
Drug: 30 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g/day milled flaxseed for 12 weeks
Trial: 31689127
Drug: Dermalax injection
RxNorm normalized name: Dermal-Soothe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermalax injection
Trial: 31689127
Drug: Restylane injection
RxNorm normalized name: Restylane
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restylane injection
Trial: 28701670
Drug: Compound Hypertonic
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound Hypertonic Saline Solution (C‐HSS) with high dose furosemide (100 mg) plus C‐HSS (100 mL) twice daily
Trial: 28701670
Drug: Furosemide intravenous
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide intravenous bolus (100 mg) twice a day without C‐HSS
Trial: 20875370
Drug: Ticagrelor 900
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor 900 mg
Trial: 15463871
Drug: Nebulised rhDNase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised rhDNase (2.5 mg)
Trial: 15463871
Drug: NaCl 0.9%
RxNorm normalized name: DEXTROSE 5%/NACL 0.9% INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaCl 0.9% (10 ml)
Trial: 31676515
Drug: Gauze and
RxNorm normalized name: tubular gauze and rubber dressing protector (fingers, toes) 7/8" X 9" TOPICAL BANDAGE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gauze and tape dressing changed once daily
Trial: 15749623
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein diet (25 g soy/4.2 MJ)
Trial: 15749623
Drug: Isoflavone diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavone diet (50 mg isoflavones/4.2 MJ)
Trial: 11927473
Drug: Propofol anesthesia
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol anesthesia with rocuronium (0.5 mg/kg at induction, followed by 0.3 mg/kg one hour later)
Trial: 11764012
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg triazolam
Trial: 28972191
Drug: Daily acute
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily acute intermittent hypoxia (AIH) + hand opening practice
Trial: 19672601
Drug: Body Awareness
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Body Awareness Therapy
Trial: 16876249
Drug: VEGF Trap
RxNorm normalized name: Trapa bicornis seed extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VEGF Trap 0.3 mg/kg
Trial: 16876249
Drug: VEGF Trap
RxNorm normalized name: Trapa bicornis seed extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VEGF Trap 1.0 mg/kg
Trial: 16876249
Drug: VEGF Trap
RxNorm normalized name: Trapa bicornis seed extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VEGF Trap 3.0 mg/kg
Trial: 12152639
Drug: Laparoscopic transabdominal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic transabdominal preperitoneal patch technique (TAPP)
Trial: 10200011
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aerosol 88 microg twice daily
Trial: 10200011
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aerosol 220 microg twice daily
Trial: 10200011
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide aerosol 200 microg 4 times daily
Trial: 10200011
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide aerosol 400 microg twice daily
Trial: 8153939
Drug: Prednisone 10
RxNorm normalized name: prednisone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 10 mg once daily
Trial: 1977869
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein (2.5‐3.0 g/kg), high calorie (BEE x 1.2 x 1.6) diet
Trial: 1977869
Drug: Normal protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal protein (1‐1.5 g/kg), normal calorie (30‐35 Kcal/kg) diet
Trial: 21762871
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (4.6 g/day of long-chain ω-3 fatty acids)
Trial: 30860197
Drug: Short-stay protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-stay protocol (ambulated and graded oral intake initiated from 6 h post-operation, urethral catheters discontinued at 12 h, discharged on the 3rd day post-op)
Trial: 30860197
Drug: Traditional protocol
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional protocol (ambulated from 12 h, graded oral intake initiated at 24 h, urethral catheters removed at 24 h, discharged on the 5th day post-op)
Trial: 15031565
Drug: Subjects with
RxNorm normalized name: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subjects with slightly elevated CRP levels (> or =1.8 mg/l)
Trial: 9690059
Drug: Outpatient structured
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient structured diabetes treatment and teaching programme (DTTP)
Trial: 29091516
Drug: Bosutinib 400
RxNorm normalized name: bosutinib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bosutinib 400 mg once daily (n = 268)
Trial: 26634593
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) at dosage of 4000 UI
Trial: 19563193
Drug: Acupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture plus Chinese medicine (group ACUP+CM)
Trial: 19563193
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine group (group CM)
Trial: 18705976
Drug: B vitamins
RxNorm normalized name: B-50 Hi Potency B Vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B vitamins (folic acid 2 mg, B(6) 25 mg, B(12) 500 microg)
Trial: 3136954
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg t-PA over 6 hours
Trial: 3136954
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg t-PA over 6 hours
Trial: 24283931
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg once weekly or twice weekly for 12 weeks
Trial: 28900875
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg once weekly for 24 weeks
Trial: 29373701
Drug: Etanercept treatment
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept treatment
Trial: 18171701
Drug: Synthetic L-T3
RxNorm normalized name: L-T3
DrugBank: Liothyronine (DB00279)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synthetic L-T3 infusion (initial dose: 20 microg/m(2) body surface.d)
Trial: 16829189
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment directed by plasma NTproBNP
Trial: 1290244
Drug: Oral hydrolytic
RxNorm normalized name: THICK & EASY HYDROLYTE (HONEY) ORAL LIQ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hydrolytic enzymes
Trial: 1290244
Drug: Oral gold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral gold salts
Trial: 6207731
Drug: Topical interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical interferon treatment for adenoviral conjunctivitis
Trial: 6207731
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment for adenoviral conjunctivitis
Trial: 30036516
Drug: Potassium citrate
RxNorm normalized name: Potassium Citrate
DrugBank: Potassium (DB14500)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Potassium citrate 20 mEq twice daily
Trial: 27765184
Drug: Spironolactone 25
RxNorm normalized name: spironolactone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 25 mg/day for 6 months
Trial: 17332474
Drug: Meal A
RxNorm normalized name: Yardley Oatmeal and Almond Bath Bar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meal A (500-ml 15% oil emulsion with 2.5% stable emulsifier)
Trial: 17332474
Drug: Meal B
RxNorm normalized name: ameal bp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meal B (500-ml 15% oil emulsion with 2.5% unstable emulsifier)
Trial: 11486635
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg aspirin + 50 mg caffeine
Trial: 11486635
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg aspirin + 0 mg caffeine
Trial: 11486635
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg aspirin + 50 mg caffeine
Trial: 11486635
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg aspirin + 100 mg caffeine
Trial: 29624723
Drug: RT001 (1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT001 (1.8 or 9.0 g/day)
Trial: 24660674
Drug: Coordinated Anxiety
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coordinated Anxiety Learning and Management (CALM) intervention (CBT, medication, or both)
Trial: 20632490
Drug: Autogenous PRP
RxNorm normalized name: Autogene cevumeran
DrugBank: Autogene cevumeran (DB17497)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autogenous PRP gel with acellular xenogeneic dermal matrix (PRP group)
Trial: 17547800
Drug: Enoxaparin (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (0.75 mg/kg) intra-arterially before PCI, with a possible supplement of 0.3 mg/kg if procedural time > 90 minutes.
Trial: 12228782
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy before planned angioplasty
Trial: 10190761
Drug: 0.1% naproxen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% naproxen ophthalmic solution
Trial: 10190761
Drug: 0.2% naproxen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% naproxen ophthalmic solution
Trial: 27572248
Drug: L-selenomethionine 166
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-selenomethionine 166 µg/die
Trial: 22683257
Drug: Antioxidant therapy
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant therapy (Antox version 1.2, Pharma Nord, Morpeth, UK)
Trial: 22683257
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 tablets, 3 times/day)
Trial: 26037286
Drug: Antiplatelet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet therapy alone
Trial: 12209041
Drug: Etoricoxib 5
RxNorm normalized name: étoricoxib
DrugBank: Etoricoxib (DB01628)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib 5 mg q.d.
Trial: 12209041
Drug: Etoricoxib 10
RxNorm normalized name: étoricoxib
DrugBank: Etoricoxib (DB01628)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib 10 mg q.d.
Trial: 12209041
Drug: Etoricoxib 30
RxNorm normalized name: Etoricoxib 30 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib 30 mg q.d.
Trial: 7828793
Drug: Diltiazem (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (120 mg b.i.d.)
Trial: 9825197
Drug: Verapamil (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (120 mg b.i.d.)
Trial: 217894
Drug: HMG 2250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMG 2250 mg per day
Trial: 217894
Drug: HMG 3000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMG 3000 mg per day
Trial: 217894
Drug: HMG 2250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMG 2250 mg and 3000 mg per day
Trial: 31582355
Drug: Nivolumab (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab (240 mg for 30 min every 2 weeks)
Trial: 31582355
Drug: Chemotherapy (paclitaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (paclitaxel 100 mg/m2 once per week for 6 weeks or docetaxel 75 mg/m2 every 3 weeks)
Trial: 17086091
Drug: Fluvastatin 40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 40 mg orally at bedtime for 6 weeks
Trial: 17086091
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (12 healthy subjects, no drug administration)
Trial: 15276658
Drug: Child Beck
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Child Beck Depression Inventory (CBDI) administered to all students
Trial: 11034630
Drug: Palliative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Palliative radiation therapy with efficient fractionation schedules
Trial: 1351183
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n = 62): unrestricted diet for mothers and infants; no acaricidal treatment.
Trial: 27666156
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin epic group (20U of botulinum toxin injection into the lateral epicondyle)
Trial: 21471671
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg/day
Trial: 20164484
Drug: Low-dose platelet
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose platelet transfusion (1.1x10(11) platelets/m2)
Trial: 20164484
Drug: Medium-dose platelet
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-dose platelet transfusion (2.2x10(11) platelets/m2)
Trial: 20164484
Drug: Low-dose platelet
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose platelet transfusion
Trial: 10360655
Drug: Immunotherapy (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy (Group B, n = 14) with weekly injection of streptococcal preparation OK‐432
Trial: 1826806
Drug: Enoximone 100
RxNorm normalized name: enoximone
DrugBank: Enoximone (DB04880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoximone 100 mg three times a day
Trial: 31586784
Drug: Ibuprofen 600
RxNorm normalized name: ibuprofen 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 600 mg every 6 hours for 24 hours
Trial: 31586784
Drug: Acetaminophen 650
RxNorm normalized name: acetaminophen 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 650 mg every 6 hours for 24 hours
Trial: 25504295
Drug: eSTI screening
RxNorm normalized name: SUN PROTECTANTS/SCREENS,TOPICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eSTI screening using a home collection kit and an e-prescription for uncomplicated treatment
Trial: 25504295
Drug: Standard clinic-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard clinic-based STI screening and treatment
Trial: 21794114
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitor (perindopril)
Trial: 8586825
Drug: Beta-blocker (bisoprolol)
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker (bisoprolol)
Trial: 19802538
Drug: Intravenous dripping
RxNorm normalized name: DRIP COLLECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dripping of ganciclovir 10 mg/kg per day
Trial: 11228061
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (n = 12)
Trial: 11228061
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (GnRH agonist, GnRH agonist plus COC, GnRH agonist plus flutamide)
Trial: 1675518
Drug: Topical PUVA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical PUVA
Trial: 3287815
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g metronidazole
Trial: 6359490
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g metronidazole
Trial: 28116433
Drug: Lauromacrogol combined
RxNorm normalized name: lauromacrogols
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lauromacrogol combined with pingyangmycin injection
Trial: 28116433
Drug: Pingyangmycin injection
RxNorm normalized name: Pingyangmycin a2
DrugBank: Bleomycin A2 (DB19091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pingyangmycin injection
Trial: 24261927
Drug: Treatment satisfaction
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment satisfaction at week 6
Trial: 19800931
Drug: Vicoprofen (hydrocodone
RxNorm normalized name: Vicoprofen (hydrocodone bitartrate 7.5 MG / ibuprofen 200 MG) Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vicoprofen (hydrocodone bitartrate 7.5mg with Ibuprofen 200mg)
Trial: 19800931
Drug: Ibuprofen (200mg)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen (200mg)
Trial: 1881831
Drug: Verapamil (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (3 x 120 mg/24 hr)
Trial: 6137859
Drug: Triazolam 0.25
RxNorm normalized name: triazolam 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.25 mg, administered in the morning
Trial: 6137859
Drug: Placebo, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, administered in the morning
Trial: 31143442
Drug: 1-day (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-day (single dose) cefazolin
Trial: 22512898
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg MPH-SR
Trial: 20932900
Drug: Monodisperse salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Monodisperse salbutamol sulphate aerosols of 1.5, 3 and 6 μm mass median aerodynamic diameter in a cumulative dosing schedule of 10, 20, 40 and 100 μg
Trial: 17006439
Drug: Corticotropin-releasing hormone
RxNorm normalized name: corticotropin-releasing hormone
DrugBank: Corticorelin (DB05394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticotropin-releasing hormone (CRH) 1 microg/kg
Trial: 16130428
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of phenoterol and ipratropium bromide
Trial: 11495172
Drug: Cognitive‐behavioral/skill training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive‐behavioral/skill training therapy (CBT)
Trial: 11495172
Drug: Motivational interviewing/supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivational interviewing/supportive (MIS) therapy
Trial: 11495172
Drug: Brief intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief intervention (BI) treatment
Trial: 31520741
Drug: Immediate initiation
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Immediate initiation of etoposide with antiretroviral therapy (ART)
Trial: 28039291
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no anticoagulants)
Trial: 25715366
Drug: Conventional medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medical treatment (Control)
Trial: 10824450
Drug: Placebo 5
RxNorm normalized name: placebo 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 5 mg t.i.d.
Trial: 8003236
Drug: Oral-B P-35
RxNorm normalized name: p-chloro-3,5-xylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral-B P-35
Trial: 3548294
Drug: Prophylactic heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic heparin treatment (group I)